Only FIVE more days until our Parliament event calling on the @EU_Commission to strengthen #HealthCareSystems by adding #patientsafety into Europe's #BeatCancerPlan.
Register today to reserve your spot in the high-level discussion👉https://t.co/CaQy9iwEEa
📣 Our Summer 2022 newsletter is finally out ❗
🛌🏥 Review our achievements over the last year in the fight against #FalsifiedMedicines to enhance #patientsafety.
📅 Stay tuned to find out more and participate in our autumn events.
Download the file⬇️
https://t.co/n6cV06a3J5
💊 We can't wait to work together in the fight against criminals who sell #FalsifiedMedicines via the Internet.
Our new Director Stefan Feltens will play a key part in this important #patientsafety initiative.
Read our press release 👇
https://t.co/7bdAjF5zPt
Falsified #medicines are a worldwide challenge that is causing #PatientHarm. By acting in unison we can make the internet a safer place to buy medicine.
📣 We are glad to announce that Stefan Feltens, European Association of E-Pharmacies, has become Director of @ASOP_Europe.
📋 Are you curious about the results of the pan-European survey on medication errors we conducted in 13 countries?
➡️ Consult our new interactive dashboard and compare the answers according to the questions that interest you the most.
#patientsafety
https://t.co/fK6n5yConH
Substandard and #fakemeds can severely impact women's health.
This #InternationalWomensDay2022#IWD2022 let's say it loud and clear: there’s no place for falsified medicines in women’s health!
🔔 Our white paper on Medication Errors and Traceability will be released on March 22nd during our #ECAMET roundtable debate: we will discuss areas of improvements to protect #patientsafety across Europe.
Meet our speakers and don’t forget to register ❗
https://t.co/npe6M1MXbV
#Nanomedicines in the #EU 🇪🇺require better regulation to enhance #patientsafety
An @EMA_News Centralised Regulatory Framework would harmonise the authorisation procedure and better protect patients.
Have a look at our article at @FrontiersIn 👇
https://t.co/sukye9hpt6
🇪🇺There is a high variability across the 27 Member States in terms of risk of suffering one #medication#error in acute care settings.
#Health stakeholders from around the #EU will join us to discuss improvements to protect #patientsafety
Register here: ℹ️ https://t.co/npe6M1vlNl
Medication errors are a common cause of harm to #patients in acute care settings.
📣We are delighted to invite you to join our roundtable debate hosted by MEP @TomislavSokol to discover the results of a major pan-European survey on med errors.
https://t.co/6Y2zvlNQ1G
An analysis published in @TheLancet estimates that #AntimicrobialResistance caused more than 1M deaths in 2019! It is more urgent than ever to address this "silent pandemic" described by @WHO expert Hanan Balkhy as "an existential threat to modern medicine"https://t.co/e8sJszdwqI
We welcome the European Parliament’s expansion of the principle of #KYBC (amendment 512) recognizing that illegal content is marketed across all online intermediary services. #DSA
🕯️Happy Holidays & many thanks for your support, commitment and collaboration in 2021! Mike, Laura and Alix wish the EAASM/ASOP EU community a happy and healthy holiday season, and look forward to working with you in 2022 to advance #patientsafety & quality of care across Europe.
What will France’s role and priorities be in 2022? Here's our new guide on Paris' priorities during the upcoming 🇫🇷 French Presidency of the Council of the European Union. Contact us if you wish to engage and learn more [email protected]
🔜https://t.co/oA3y8FQmZr
📢Our 4th #FTFweek kicks off today! Join us, our members & allies in raising awareness about the dangers of substandard & #fakemeds!
Let’s take action together because #HealthIsNoHoax!
#BeAFakeBuster 💊🔍🦸♂️🦸♀️
https://t.co/7y8yXB6uCz
The🌐Patient Safety Action Plan 2021–2030 envisions a world in which no one is harmed in #health care, and every #patient receives safe and respectful care, every time. Join on #PSD2021 in calling for patients co-creating safe healthcare through the implementation of the plan.
On the occasion of the 10th anniversary of @coe @MedicrimeC I call on all countries which have not yet done so to sign and/or ratify it asap @CoE_HRightsRLaw
#Nanomedicines are unique and offer solutions for several treatment challenges. Their quality attributes are closely linked to their manufacturing process. Let's come together & discuss the need for a robust regulatory pathway to protect #patientsafety.
💻https://t.co/v8VTqB423R